Skip to main content

Table 3 Results of neutralization test with different poliovirus type 1 challenge strains in adults immunized totally or partially with OPV.

From: Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany

   

Poliovirus Type 1

Strain CHAT

Poliovirus Type 1 Strain Sabin (LSc-2ab)

   

ATTC

VR-1562

WHO reference virus

Behringwerke AG

DVV reference virus

Case No.

Age

Ratio*

GMT* (IU/ml)

GMT (IU/ml)

GMT (IU/ml)

GMT (IU/ml)

1

16

 

< 8 (< 1,1)

11 (0,6)

11 (0,8)

8 (0,8)

2

29

 

< 8 (< 1,1)

16 (0,8)

19 (1,5)

11 (1,1)

3

24

 

< 8 (< 1,1)

16 (0,8)

19 (1,5)

8 (0,8)

4

33

 

< 8 (< 1,1)

8 (0,4)

8 (0,6)

< 8 (< 1,1)

5

29

 

< 8 (< 1,1)

32 (1,7)

53 (4,1)

32 (3,3)

6

49

 

< 8 (< 1,1)

32 (1,7)

19 (1,5)

16 (1,6)

7

42

 

< 8 (< 1,1)

45 (2,4)

45 (3,5)

64 (6,6)

8

43

 

< 8 (< 1,1)

16 (0,8)

11 (0,8)

11 (1,1)

9

50

8

8 (1,1)

64 (3,4)

16 (1,2)

32 (3,3)

10

53

11

8 (1,1)

90 (4,8)

53 (4,1)

32 (3,3)

11

10

11

16 (2,2)

181 (9,7)

256 (19,7)

181 (18,7)

12

37

10

17 (2,4)

181 (9,7)

76 (5,9)

128 (13,2)

13

40

17

28 (3,9)

512 (27,5)

362 (27,9)

256 (26,5)

14

31

8

32 (4,4)

256 (13,7)

152 (11,7)

256 (26,5)

15

40

32

32 (4,4)

1024 (55)

362 (27,9)

362 (37,5)

16

44

5

45 (6,2)

256 (13,7)

181 (13,9)

181 (18,7)

17

40

11

64 (8,8)

724 (38,9)

430 (33,1)

724 (75)

18

28

5

128 (17,7)

724 (38,9)

304 (23,4)

256 (26,5)

19

18

5

128 (17,7)

724 (38,9)

512 (39,4)

512 (53)

20

37

8

128 (17,7)

1024 (55)

861 (66,3)

512 (53)

21

49

8

128 (17,7)

1024 (55)

1024 (78,9

1024 (106,1)

22

41

4

8 (1,1)

32 (1,7)

32 (2,5)

22 (2,3)

23

43

4

8 (1,1)

32 (1,7)

26 (2,0)

22 (2,3)

24

25

1

16 (2,2)

16 (0,8)

22 (1,7)

16 (1,6)

25

59

4

16 (2,2)

64 (3,4)

38 (2,9)

32 (3,3)

26

54

1

32 (4,4)

32 (1,7)

26 (2,0)

16 (1,6)

27

64

2

32 (4,4)

64 (3,4)

53 (4,1)

22 (2,3)

28

46

1

35 (4,9)

64 (3,4)

64 (4,9)

64 (6,6)

29

60

1

64 (8,8)

90 (4,8)

76 (5,9)

90 (9,3)

30

29

2

64 (8,8)

181 (9,7)

181 (13,9)

64 (6,6)

31

60

2

128 (17,7)

256 (13,7)

215 (16,6)

181 (18,7)

32

46

2

128 (17,7)

256 (13,7)

152 (11,7)

128 (13,2)

33

36

2

128 (17,7)

362 (19,4)

256 (19,7)

256 (6,5)

34

24

2

256 (35,5)

512 (27,5)

512 (39,4)

512 (53)

35

28

4

256 (35,5)

1024 (55)

724 (55,8)

512 (53)

36

37

2

512 (71,1)

1024 (55)

1024 (78,9)

1024 (106,1)

37

58

2

512 (71,1)

1024 (55)

1024 (78,9)

724 (75)

38

35

1

1024 (142,3)

1024 (55)

724 (55,8)

1024 (106,1)

39

36

1

1024 (142,3)

1024 (55)

861 (66,3)

724 (75)

40

40

1

1024 (142,3)

1024 (55)

1024 (78,9)

1024 (106,1)

41

61

1

1024 (142,3)

1024 (55)

1024 (78,9)

1024 (106,1)

  1. The sera were grouped as follows:
  2. In sera No. 1 to 8 antibody titres against the strain CHAT were lower than 1: 8.
  3. In sera No. 9 to 21 antibodies titre against the strain CHAT were five or more fold lower than against the strain Sabin.
  4. In sera from No. 22 to 41 the difference between antibodies titre against the strain CHAT and the strain Sabin was fourfold and less.
  5. Case numbers in Tables 1 and 2 correspond to the case numbers in Table 3.
  6. *Ratio of titre against Sabin 1 WHO reference strain to titre against CHAT
  7. **GMT Reciprocal geometric mean titers